The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Weyer Christian since year 2005.
The trader's CIK number is 1493811.
At the time of the last reporting, Weyer Christian was the SVP, Research & Development of Intercept Pharmaceuticals, Inc. .
(stock ticker symbol ICPT).
See this page for all insider trading activities at Intercept Pharmaceuticals, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-03-01||ICPT||Intercept Pharmaceuticals, Inc.||Sale||333||103.16||34,352|
|2018-11-29||ICPT||Intercept Pharmaceuticals, Inc.||Sale||1,343||113.78||152,806|
|2015-04-13||FATE||Fate Therapeutics Inc||Option Ex||25,000||1.37||34,250|
|2014-04-01||FATE||Fate Therapeutics Inc||Option Ex||7,738||1.37||10,601|
|2014-04-02||FATE||Fate Therapeutics Inc||Option Ex||2,262||1.37||3,098|
|2014-04-01||FATE||Fate Therapeutics Inc||Sale||7,738||9.02||69,789|
|2014-04-02||FATE||Fate Therapeutics Inc||Sale||2,262||9.02||20,394|
|2012-03-01||AMLN||Amylin Pharmaceuticals Inc||Sale||1,231||17.11||21,062|
|2012-02-23||AMLN||Amylin Pharmaceuticals Inc||Sale||2,519||17.03||42,898|
|2012-02-08||AMLN||Amylin Pharmaceuticals Inc||Sale||3,843||16.61||63,851|
|2010-11-19||AMLN||Amylin Pharmaceuticals Inc||Sale||1,314||13.42||17,633|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Weyer Christian (SVP, Research & Development of Intercept Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.